Literature DB >> 27461365

Authors' Reply.

Olga Frunza1, Ilaria Russo1, Arti V Shinde1, Ya Su1, Nikolaos G Frangogiannis2.   

Abstract

This correspondence is a reply to Galectin-3, Cardiac Function, and Fibrosis by Wouter C. Meijers et al.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2016        PMID： 27461365      PMCID： PMC4973651          DOI： 10.1016/j.ajpath.2016.06.001

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


  7 in total

Review 1.  Galectin-3 in heart failure with preserved ejection fraction.

Authors:  Rudolf A de Boer; Frank Edelmann; Alain Cohen-Solal; Mamas A Mamas; Alan Maisel; Burkert Pieske
Journal:  Eur J Heart Fail       Date:  2013-05-05       Impact factor: 15.534

2.  Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.

Authors:  Lili Yu; Willem P T Ruifrok; Maxi Meissner; Eelke M Bos; Harry van Goor; Bahram Sanjabi; Pim van der Harst; Bertram Pitt; Irwin J Goldstein; Jasper A Koerts; Dirk J van Veldhuisen; Ruud A Bank; Wiek H van Gilst; Herman H W Silljé; Rudolf A de Boer
Journal:  Circ Heart Fail       Date:  2012-12-10       Impact factor: 8.790

3.  The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries.

Authors:  Laurent Calvier; Ernesto Martinez-Martinez; Maria Miana; Victoria Cachofeiro; Elodie Rousseau; J Rafael Sádaba; Faiez Zannad; Patrick Rossignol; Natalia López-Andrés
Journal:  JACC Heart Fail       Date:  2014-11-11       Impact factor: 12.035

Review 4.  Galectin-3 and heart failure: prognosis, prediction & clinical utility.

Authors:  Mando D Filipe; Wouter C Meijers; A Rogier van der Velde; Rudolf A de Boer
Journal:  Clin Chim Acta       Date:  2014-10-18       Impact factor: 3.786

5.  Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis.

Authors:  Olga Frunza; Ilaria Russo; Amit Saxena; Arti V Shinde; Claudio Humeres; Waqas Hanif; Vikrant Rai; Ya Su; Nikolaos G Frangogiannis
Journal:  Am J Pathol       Date:  2016-03-03       Impact factor: 4.307

6.  Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension.

Authors:  Ernesto Martínez-Martínez; Laurent Calvier; Amaya Fernández-Celis; Elodie Rousseau; Raquel Jurado-López; Luciana V Rossoni; Frederic Jaisser; Faiez Zannad; Patrick Rossignol; Victoria Cachofeiro; Natalia López-Andrés
Journal:  Hypertension       Date:  2015-08-03       Impact factor: 10.190

Review 7.  The inflammatory response in myocardial injury, repair, and remodelling.

Authors:  Nikolaos G Frangogiannis
Journal:  Nat Rev Cardiol       Date:  2014-03-25       Impact factor: 32.419
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.